clinical trials

Private equity-backed Headlands Research heralded its COVID vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.

The medical director at Accel Research Sites in DeLand expects a shot for RSV to be available by the new year and a combination RSV, COVID and flu shot by next fall.

The only Lyme vaccine for humans was pulled off the U.S. market in 2002 from lack of demand, leaving people to rely on bug spray and tick checks.

The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.

Drug manufacturers invested in Russia’s pharmaceutical industry contend international humanitarian law requires they continue manufacturing and selling their products there, even while condemning the Ukraine invasion.

About 200 people are expected to be enrolled in the UF Health component of the trial, with about 15,000 participating nationwide

Pfizer studied a lower dose of its vaccine in more than 2,200 kindergartners and elementary school-aged kids. They developed coronavirus-fighting antibody levels as strong as teens and young adults.

When a new drug is up for FDA approval, trials may be held not only in the U.S. but other countries too. A study looks at global availability after approval. Big Pharma disagrees with the findings.

Parents who have enrolled their children in these studies say the risk is worth it for the greater good.

A rheumatologist in Miami-Dade seeks volunteers for a double-blind, placebo-controlled pilot study to test a drug that would treat COVID-19 long-hauler syndrome.